Divincell
  • Accueil
  • Technologie
  • Nos programmes
  • L’équipe
  • Actualité
  • Contact
  • EN
Sélectionner une page

Aanastra Inc and Divincell SAS present a “A new Peptide nanoparticle platform for extrahepatic targeted delivery of therapeutic mRNAs”

Aanastra Inc and Divincell SAS present a “A new Peptide nanoparticle platform for extrahepatic targeted delivery of therapeutic mRNAs” and “mRNA delivery for Factor VIII rescue in hemophilia and gene editing of PCSK9 for cholesterol lowering” at the 31st European Society of Gene and Cell Therapy (ESGCT) Annual Congress, Rome. October 22-25, 2024

← Aanastra Inc and Divincell to Showcase its Peptide-RNA Therapeutics Technology Aanastra Inc and Divincell SAS present a “Peptide-based nanoparticle platform for extrahepatic →

22 octobre 2024

Last posts
Nos dernières parutions
  • Aanastra Inc and Divincell SAS will be presenting  “the PEP-NP
  • Aanastra Inc and Divincell  to highlight its technology in Multiple Presentations
  • Aanastra Inc and Divincell Announce Presentations of Preclinical Data
  • Aanastra Inc/DIVINCELL present their Peptide-based Nanoparticle platform
  • Aanastra Inc/DIVINCELL present Peptide-based Nanoparticle platform
Suivez-nous
Follow us
  • Suivre
LIENS

L’équipe
Technologie
Programmes
Actu

INFORMATIONS

Confidentialité
Mentions Légales
Plan de site

DIVINCELL

442 rue Georges BESSE
30000 Nîmes
0650740869
divincell@divincell.com

Copyright © 2026 - DIVINCELL - Conception AMBE Design
  • Suivre
LINKs

Team
Technology
Programs
News

INFO

Privacy Policy
Legal Notice
Sitemap

DIVINCELL

442 rue Georges BESSE
30000 Nîmes
0650740869
divincell@divincell.com

Copyright © 2026 - DIVINCELL - Conception AMBE Design
  • Suivre